Putting people at the heart of it all!

Putting people at the heart of it all!

February 18, 2017

It would be easy to dismiss the importance of a microscope slide in the pathology laboratory, after all, put simply it is a flat piece of glass.

Trajan Scientific and Medical (Trajan) believes it is much much more than this, and invite pathology laboratories to work with our range of Trajan microscope slides to make a real difference to their workflow.

At the heart of Trajan is our belief in improving the wellbeing of people. This translates into quality products that do not compromise on performance at any cost.

Understanding the affect that the surface coating functionality has on the performance of a slide, and impact on diagnosis is central to Trajan’s adhesive microscope slides portfolio. 

Breast cancer diagnosis in particular can benefit from the Trajan Series 2 adhesive microscope slides, that have a specialized coating in tandem with reduced background staining, provide improved tissue section adherence and extensibility.

View our range to find out how Trajan’s microscope slides can assist with better diagnosis, improved efficiency and workflow for your pathology laboratory.

Media contact information
Trajan Scientific and Medical
media@trajanscimed.com
+44 (0) 1244 403 100




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More